Funding opportunities
38 live opportunities from Grants.gov, NIH, NSF, and more.
Small Business (SBIR/STTR)× remove
- Forecast to Publish a Notice of Funding Opportunity for SBIR Phase IIB Bridge Awards to Accelerate the Development of Cancer-Relevant Technologies Toward Commercialization (R44 Clinical Trial Optional)National Institutes of HealthFOR-CA-25-086forecastedgrants.gov
- Forecast to Publish a Notice of Funding Opportunity for Small Business Transition Grant For Early Career Scientists (R41/R42 Clinical Trial Not Allowed)National Institutes of HealthFOR-CA-25-087forecastedgrants.gov
- Small Business Innovation Research Program (SBIR) Phase IIAdministration for Community LivingHHS-2026-ACL-NIDILRR-BISB-0208forecastedgrants.gov
- Small Business Innovation Research (SBIR) program, Phase IAdministration for Community LivingHHS-2026-ACL-NIDILRR-BISA-0207forecastedgrants.gov
- Small Business Translator: MedTech and Digital Health TechnologiesNational Institutes of HealthFOR-NS-25-017forecastedgrants.gov
- NASA Innovative Advanced Concepts (NIAC) Phase IINASA HeadquartersNNH26ZTR001N-26NIAC-A2postedgrants.gov
- Small Business Transition Grant for New Entrepreneurs (Parent R43/R44 Clinical Trial Optional)National Institutes of HealthPAR-27-039forecastedgrants.gov
- Small Business Transition Grant for New Entrepreneurs (Parent R41/R42 Clinical Trial Optional)National Institutes of HealthPAR-27-040forecastedgrants.gov
- NIEHS Worker Training Program’s SBIR E-Learning for HAZMAT and Emergency Response (R43/R44 Clinical Trial Not Allowed)National Institutes of HealthTEMP-30794forecastedgrants.gov
- Leveraging Extended Reality Exergaming and Telehealth to Improve Physical Activity and Health in Children with DisabilitiesEunice Kennedy Shriver National Institute of Child Health and Human DevelopmentPA-25-305 closes 5/31/2031up to $640,699activenih
- Reducing Intratumoral Bacteria to Enhance Anti-Tumor Immunity in Oral Squamous Cell CarcinomaNational Cancer InstitutePAR-25-081 closes 5/31/2031up to $640,775activenih
- Factory-treated, long-lasting permethrin baby wraps for the prevention of malaria: A phase III randomized controlled trialNational Institute of Allergy and Infectious DiseasesPA-25-305 closes 5/31/2031up to $1,235,114activenih
- Natural Products Magnetic Resonance Database (NP-MRD) Phase IINational Center for Complementary and Integrative HealthRFA-AT-24-007 closes 5/31/2031up to $478,106activenih
- A Patient-Specific Magnetic Resonance Guided Focused Ultrasound System for Breast Cancer TreatmentNational Cancer InstitutePAR-25-081 closes 5/31/2031up to $625,791activenih
- Spatial and Temporal control of gene therapy in CAR-T cells with ionizing radiation to improve local and distant control of solid tumorsNational Cancer InstitutePA-25-301 closes 5/31/2031up to $651,674activenih
- Biostatistics, Ethics, Data Management, Research Design and Community Engagement(BEDRoC) CoreNational Institute of General Medical SciencesPAR-22-250 closes 3/31/2031up to $816,878activenih
- Uncovering the structure and function of understudied membrane proteinsNational Institute of General Medical SciencesPAR-22-180 closes 2/28/2031up to $375,154activenih
- SBIR/STTR Commercialization Readiness Pilot (CRP) Program (Parent SB1 Clinical Trial Optional)National Institutes of HealthPAR-27-098 closes 4/5/2029postedgrants.gov
- NIH Small Business Innovation Research (SBIR) Phase IIB Strategic Breakthrough Award (Parent [R44] Clinical Trial Optional)National Institutes of HealthPA-27-101 closes 4/5/2029postedgrants.gov
- Evaluation of genetic and epigenetic determinants of response in patients with accelerated and blast phase Myeloproliferative Neoplasm (MPNs)National Cancer InstitutePAR-25-139 closes 5/31/2028up to $444,590activenih
- Evaluating the Synergistic Therapeutic Effects of Retinoic Acid and the Proteasome Inhibitors in NeuroblastomaNational Cancer InstitutePAR-25-139 closes 5/31/2028up to $467,968activenih
- Targeting subtype specification as a driver of PDAC health disparitiesNational Cancer InstitutePAR-25-139 closes 5/31/2028up to $394,687activenih
- Development of Gene Therapy Approaches to Cerebellar CACNA1A disordersNational Institute of Neurological Disorders and StrokePA-25-150 closes 5/31/2028up to $439,588activenih
- I3-BC: Image-Based Infiltrating Immune Cell Detection and Outcomes in Breast Cancer Clinical TrialsNational Cancer InstitutePAR-25-139 closes 5/31/2028up to $394,695activenih
- How Feedback Shapes Sensory Representations During CognitionNational Institute of Neurological Disorders and StrokeRFA-NS-24-030 closes 5/31/2028up to $44,714activenih
Page 1 of 2